NASDAQ$AKYA

Akoya Biosciences Inc · Q3 2023 earnings

Q3 2023 earnings · · Investor relations

Briefing

Akoya reported record revenue with strong financial performance and maintained stable operating expenses.

Akoya Biosciences reported a record revenue of $25.2 million for Q3 2023, a 34% increase compared to the previous year. The company is focused on improving workflow throughput and expanding its menu of ready-to-use panels.

  • Total revenue reached $25.2 million, a 34% increase year-over-year.
  • Product revenue increased by 25% to $18.0 million.
  • Service and other revenue increased by 62% to $7.2 million.
  • Gross profit increased by 40% to $15.3 million with a gross profit margin of 60.6%.

Headline financials

Total Revenue

$25.2M

Previous: $18.9M+33.8%
EPS (adj)

-$0.26

Previous: -$0.47+44.7%
Capital Expenditures

-$832K

Previous: $3.79M-122.0%
Free Cash Flow

-$14.6M

Previous: -$16M+8.6%
Net Income

-$12.9M

Previous: -$17.9M+27.7%
Operating Income

-$11.6M

Previous: -$16.3M+29.1%
Gross Profit

$15.3M

Previous: $10.9M+40.1%
Cash & Equivalents

$78.6M

Previous: $51.8M+51.6%
Total Assets

$177M

Previous: $176M+0.4%
R&D Expense

$5.17M

No prior period
Stock-Based Comp

$2.88M

Previous: $2.04M+40.8%

Revenue & EPS history

Akoya · Revenue · Quarterly

$25.2M

Q3 2023+33.8%vs Q3 2022
Beat estimate in 9 of 15 quarters(60%)
ActualEstimate

Revenue by segment

Akoya · $18M total across 1 segment · Q3 2023

  • Product revenue
    $18M+25.3%

Forward guidance

The company continues to expect full year 2023 revenue in the range of $95-98 million.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 10 quarterly earnings reports · overlaid with Q3 2023

Historical avgQ3 2023

-3.7%

Avg return

Earnings day

-8.6%

Avg return

5 days after

-17.2%

Avg return

30 days after

53%

10 / 19 earnings

Positive

+13.7%

Q4 2021

Best reaction

-31.9%

Q1 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2025
Q2 2025
Q1 2025+1.0%+24.8%+23.8%
Q4 2025+3.8%+9.2%-30.7%
Q3 2024-24.9%-33.2%-29.5%
Q2 2024-9.5%-0.9%+5.5%
Q1 2024-31.9%-35.1%-50.0%
Q4 2023-15.4%-17.1%-28.1%
Q3 2023+10.0%+6.9%+16.4%
Q2 2023+0.9%-6.5%-23.9%
Q1 2023-2.5%-17.1%-18.8%
Q4 2022-7.3%-17.2%-36.6%
Q3 2022-15.1%
Q2 2022+5.0%
Q1 2022-11.9%
Q4 2021+13.7%
Q3 2020+1.5%
Q3 2021+0.2%
Q2 2021-0.1%
Q4 2020+9.5%
Q1 2021+2.3%
Q2 2020
Q1 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro